查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095671

新冠病毒即時檢測試劑盒市場－全球市場預測（2026-2032年）

COVID-19 Detection PoC Kits Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，COVID-19 檢測概念驗證試劑盒的市場規模將成長至 62.8 億美元，複合年成長率為 7.18%。

主要市場統計數據
基準年 2025 38.6億美元
預計年份：2026年 41.4億美元
預測年份 2032 62.8億美元
複合年成長率 (%) 7.18%

新冠病毒檢測即時檢驗試劑盒：執行摘要與策略背景

用於新冠病毒檢測的即時檢測（PoC）試劑盒已成為分散式診斷的關鍵組成部分，能夠幫助醫院、急診中心、藥房、職場、學校、機場和社區醫療機構快速做出臨床決策。這些試劑盒包括抗原檢測、快速分子檢測和「檢體到結果」平台，旨在患者附近識別SARS-CoV-2感染，從而減少對中心實驗室檢測的依賴和等待時間。隨著醫療系統應對季節性呼吸道疾病激增、新出現的變異株和合併感染疾病，以及區分新冠病毒與流感、呼吸道融合細胞病毒和其他呼吸道病原體的實際需求，這些試劑盒的重要性仍然不減。

變革性變化將重新定義新冠病毒即時偵測

新冠病毒即時檢測試劑盒的模式已從緊急採購和大規模檢測轉向以臨床主導的綜合診斷。在疫情初期，快速抗原檢測因其速度快、擴充性和易用性而被廣泛採用，尤其是在檢查室能力有限的情況下。隨著疫苗接種、混合免疫、病毒變異株的出現以及公共衛生政策的調整，檢測行為發生了改變，需求也隨之轉向針對高風險族群、有症狀者、醫療機構、長期照護機構以及易發疫情環境的定向檢測。

人工智慧在新冠肺炎概念驗證診斷上的累積影響

人工智慧正從產品開發、臨床檢驗、品質保證、分銷規劃到實際部署等諸多方面影響新冠病毒檢測概念驗證試劑盒。在檢測套組開發方面，人工智慧驅動的生物資訊學可以輔助設計分子檢測的引子和探針，監測與變異相關的序列變化，並幫助評估突變對檢測目標區域的潛在影響。在生產和品管系統方面，機器視覺和預測分析可以改善側向流動偵測系統和盒式的平台中的缺陷檢測、批次監控和流程一致性。

亞太地區、北美地區、拉丁美洲地區、歐洲地區以及中東和非洲地區的關鍵區域洞察

亞太地區憑藉其龐大的人口基數、強大的診斷設備製造能力以及大規模感染疾病監測經驗，仍然是新冠病毒即時檢測試劑盒生產、分銷和創新的核心。儘管該地區醫院、社區診所、旅行者醫療保健和疫情控制的快速檢測基礎設施正在不斷擴展，但市場需求正日益轉向多重呼吸道檢測和數位連接的診斷設備。北美地區的特點是監管流程完善、家庭和藥房檢測廣泛普及，以及在臨床分診、職業健康、長期護理和公共衛生應急準備等領域持續使用快速診斷技術。數位化報告、報銷政策以及檢查室與即時檢測設備的整合是推動其應用的關鍵因素。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東協地區，新冠病毒檢測的概念驗證（PoC）試劑盒正在支援分散式醫療保健服務，這些服務涵蓋不同的醫療體系、島嶼地區、都市區差距以及交通繁忙的走廊。該地區的需求日益受到公共衛生監測、基層醫療以及在呼吸道疾病高發季節對價格合理、快速診斷的需求的影響。海灣合作理事會（GCC）憑藉其技術先進的醫療服務體系、數位化醫療整合、機場和大型活動應急準備以及以醫院為基礎的快速診斷（優先考慮聯網的PoC檢測和多參數呼吸道病原體檢測），為這些服務提供了有利的環境。在整個歐盟，通用的法規結構、跨境公共衛生協調以及對臨床證據的高度重視，正在推動檢測品質、可追溯性和負責任部署的更高標準。

主要新冠病毒即時檢測市場的關鍵國家特定趨勢

在美國，居家和專門的COVID-19概念驗證（PoC）檢測擁有豐富的經驗，並獲得了緊急使用授權、藥房供應、遠端醫療報告以及在高風險環境中持續的臨床應用支援。在加拿大，公共衛生管治、省級醫療保健服務系統以及為醫療機構、偏遠社區和疫情控制提供品質保證的診斷服務備受重視。在墨西哥，PoC試劑盒正被用於擴大檢測範圍，使其不再局限於中心實驗室，尤其是在基層醫療、邊境地區和人口稠密的都市區。巴西地域遼闊，公私醫療保健體系混合，因此認知到分散式檢查對於呼吸道疾病監測、醫院分診以及確保服務不足地區獲得檢測的重要性。

關於新冠病毒檢測概念驗證試劑盒的領導者實用建議

產業領導者應優先開發經臨床檢驗且符合監管規定的新冠病毒檢測概念驗證（PoC）試劑盒，以應對當前呼吸道疾病的實際情況，而不是依賴基於疫情需求預測的大規模生產。產品系列應日益整合多參數呼吸道檢測、高性能抗原檢測、快速分子檢測以及支持可靠結果獲取、品管和公共衛生報告的數位化整合工作流程。易用性應始終是核心設計要求，尤其是在自我檢測、藥房檢測、社區診所和非檢查室醫療機構等場景下。

新冠病毒檢測概念驗證試劑盒分析的調查方法

本執行摘要採用系統性的二手研究途徑撰寫，重點在於檢驗、資料支持的公共資訊來源和產業相關證據。調查方法借鑒了衛生部門、監管機構和標準化機構的指南和出版刊物、同行評審的科學文獻、公共衛生監測資源、醫療設備法規更新以及診斷領域的最佳實踐文件。分析評估了技術類型、臨床應用案例、監管考慮、區域醫療保健系統優先事項、部署環境和新興創新主題，而不依賴市場規模、市場佔有率或預測數據。

結論：COVID-19 PoC試劑盒是建構可靠的呼吸道診斷系統的基礎。

用於新冠病毒檢測的概念驗證 (PoC) 試劑盒在快速診斷、臨床分流、疫情控制和呼吸道疾病監測方面繼續發揮至關重要的作用。該領域已從應對突發疫情的緊急措施發展成為一個更加成熟的診斷環境，其特點是品質高、易於使用、符合監管要求、具備數位連接性，並能與更廣泛的呼吸道檢測方法整合。抗原檢測、快速分子檢測和多重檢測平台分別針對不同的醫療機構、社區服務點和資源限制等不同情況，滿足各自的獨特需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：新冠病毒檢測即時檢驗試劑盒市場：依產品類型分類

  • 分子即時檢測套組
  • 抗原即時檢測套組
  • 抗體即時檢測套組
  • 多參數呼吸道即時檢測套組

第8章：新冠病毒即時檢測試劑盒市場：依檢測技術分類

  • 橫向流動化驗技術
  • 逆轉錄聚合酵素鏈鎖反應（RT-PCR）技術
  • 恒溫核酸增幅技術
  • CRISPR診斷技術
  • 螢光免疫分析
  • 微流體技術
  • 生物感測器技術

第9章：COVID-19 即時檢測試劑盒市場：依樣本類型分類

  • 鼻咽拭子
  • 口腔和咽拭子
  • 唾液
  • 鼻拭子檢體
  • 血液檢體
  • 痰液檢體

第10章：新冠病毒檢測即時檢驗試劑盒市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第11章：新冠病毒檢測即時檢驗試劑盒市場：依應用領域分類

  • 臨床試驗
  • 研究
  • 自我檢查
  • 監視

第12章：新冠病毒檢測即時檢驗試劑盒市場：依最終用戶分類

  • 診斷中心
  • 居家照護
  • 醫院

第13章：新冠病毒即時檢測試劑盒市場：依使用方法分類

  • 商用POC套件
  • 自測式即時檢測試劑盒

第14章：新冠病毒即時檢測試劑盒市場：依檢測結果可用性分類

  • 不到15分鐘
  • 15-30分鐘
  • 超過30分鐘

第15章：新冠病毒即時檢測試劑盒市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第16章：新冠病毒檢測即時檢驗試劑盒市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章：新冠病毒檢測即時檢驗試劑盒市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • Abbott Laboratories
  • Access Bio, Inc.
  • ACON Laboratories, Inc.
  • ANP Technologies, Inc.
  • Azure Biotech, Inc.
  • Becton, Dickinson And Company
  • bioMerieux SA
  • CorDx Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd
  • Genabio Diagnostics Inc.
  • GenBody Inc.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • iHealth Labs, Inc.
  • InBios International, Inc.
  • Lex Diagnostics Limited
  • Maxim Biomedical, Inc.
  • MicroGEM US, Inc.
  • Nano-Ditech Corporation
  • Nuclein, LLC
  • OSANG Healthcare Co., Ltd.
  • Pfizer Inc.
  • Princeton BioMeditech Corporation
  • QIAGEN NV
  • Qorvo, Inc.
  • QuidelOrtho Corporation
  • SD Biosensor, Inc.
  • SEKISUI Chemical Co., Ltd.
  • Shenzhen Watmind Medical Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Visby Medical, Inc.
  • Xiamen Boson Biotech Co., Ltd.
  • Zhejiang Orient Gene Biotech Co., Ltd.
Product Code: MRR-205091A88F53

The COVID-19 Detection PoC Kits Market is projected to grow by USD 6.28 billion at a CAGR of 7.18% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.86 billion
Estimated Year [2026] USD 4.14 billion
Forecast Year [2032] USD 6.28 billion
CAGR (%) 7.18%

COVID-19 Detection PoC Kits: Executive Summary and Strategic Context

COVID-19 detection point-of-care kits have become a critical component of decentralized diagnostics, enabling rapid clinical decision-making in hospitals, urgent care centers, pharmacies, workplaces, schools, airports, and community health settings. These kits include antigen tests, rapid molecular tests, and sample-to-answer platforms designed to identify SARS-CoV-2 infection closer to the patient, reducing dependence on centralized laboratory turnaround times. Their relevance remains high as health systems manage seasonal respiratory illness surges, emerging variants, co-infections, and the operational need to distinguish COVID-19 from influenza, respiratory syncytial virus, and other respiratory pathogens.

The COVID-19 detection PoC kits landscape is shaped by evidence-based requirements for sensitivity, specificity, usability, biosafety, quality control, and regulatory compliance. While laboratory-based RT-PCR remains a reference method for confirming infection, PoC testing supports faster triage, isolation decisions, treatment eligibility assessment, and infection control. The sector is increasingly moving toward multiplex respiratory panels, digital result reporting, telehealth-linked testing, and AI-enabled workflow optimization, reflecting the transition from emergency pandemic response to sustainable respiratory disease surveillance.

Transformative Shifts Reshaping COVID-19 Point-of-Care Testing

The landscape for COVID-19 detection PoC kits has transformed from emergency procurement and mass testing to integrated, clinically governed diagnostics. During the early pandemic response, rapid antigen tests were widely adopted because they offered speed, scalability, and ease of use, particularly when laboratory capacity was constrained. As vaccination, hybrid immunity, variant evolution, and changing public health policies altered testing behavior, demand shifted toward targeted testing in high-risk populations, symptomatic individuals, healthcare environments, long-term care facilities, and outbreak-prone settings.

A major structural shift is the convergence of COVID-19 testing with broader respiratory diagnostics. Healthcare providers increasingly prefer testing solutions that can differentiate SARS-CoV-2 from influenza A, influenza B, and RSV using a single specimen, especially during overlapping respiratory virus seasons. Regulatory expectations have also matured, with greater emphasis on clinical performance against variants, clear instructions for self-testing or professional use, lot-to-lot consistency, digital traceability, and post-market performance monitoring. Procurement decisions are now influenced by shelf life, storage conditions, supply continuity, ease of reporting, connectivity with electronic health records, and compatibility with decentralized care models.

Cumulative Impact of Artificial Intelligence on COVID-19 PoC Diagnostics

Artificial intelligence is influencing COVID-19 detection PoC kits across product development, clinical validation, quality assurance, distribution planning, and real-world deployment. In test development, AI-enabled bioinformatics can support primer and probe design for molecular assays, monitor variant-associated sequence changes, and help assess whether mutations may affect assay target regions. In manufacturing and quality systems, machine vision and predictive analytics can improve defect detection, batch monitoring, and process consistency for lateral flow devices and cartridge-based platforms.

At the point of care, AI-enabled image interpretation can support standardized reading of test strips, reducing variability caused by faint lines, lighting conditions, or user interpretation errors. Digital apps linked to PoC kits can guide sample collection, time-to-read adherence, identity verification, and secure result reporting. AI also strengthens public health intelligence by aggregating de-identified testing data to detect geographic clusters, unusual positivity patterns, and respiratory disease trends. However, successful AI integration requires transparent validation, cybersecurity controls, privacy-by-design architecture, bias assessment, and alignment with medical device regulations, particularly where algorithms influence diagnostic interpretation or clinical workflow decisions.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific remains central to COVID-19 detection PoC kit production, adoption, and innovation because of its large population base, significant diagnostic manufacturing capacity, and experience with large-scale infectious disease surveillance. Countries across the region have expanded rapid testing infrastructure for hospitals, community clinics, travel health, and outbreak management, while demand increasingly favors multiplex respiratory assays and digitally connected diagnostics. North America is characterized by established regulatory pathways, strong adoption of home-based and pharmacy-based testing, and continued use of rapid diagnostics in clinical triage, occupational health, long-term care, and public health preparedness. Digital reporting, reimbursement policy, and laboratory-to-PoC integration are important factors shaping utilization.

Latin America continues to use PoC kits to address gaps in laboratory access, especially across geographically dispersed communities and resource-constrained healthcare settings. The region's priorities include affordability, reliable supply chains, professional training, and kits that perform well under varied storage and transport conditions. Europe has moved from emergency testing toward regulated, quality-assured respiratory diagnostics, with emphasis on conformity assessment, clinical evidence, surveillance integration, and responsible antimicrobial and antiviral stewardship. The Middle East has leveraged PoC testing within travel medicine, hospital networks, mass-gathering preparedness, and government-led digital health systems, with growing interest in multiplex platforms that support rapid respiratory triage. Africa's needs are strongly linked to decentralized healthcare delivery, cross-border disease surveillance, donor-supported diagnostics capacity, and tests that are robust, simple to deploy, and compatible with limited laboratory infrastructure.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

Within ASEAN, COVID-19 detection PoC kits support decentralized care across diverse healthcare systems, island geographies, urban-rural divides, and high-volume travel corridors. Regional demand is increasingly shaped by public health surveillance, primary care access, and the need for affordable rapid diagnostics during respiratory illness peaks. The GCC has prioritized technologically advanced healthcare delivery, digital health integration, airport and mass-event readiness, and hospital-based rapid diagnostics, creating favorable conditions for connected PoC testing and multiplex respiratory panels. Across the European Union, common regulatory frameworks, cross-border public health coordination, and strong emphasis on clinical evidence have encouraged higher standards for test quality, traceability, and responsible deployment.

BRICS economies represent a diverse diagnostic environment combining large populations, domestic manufacturing ambitions, infectious disease surveillance needs, and expanding healthcare access. In these countries, COVID-19 PoC kit strategies often intersect with industrial policy, local production, cost containment, and preparedness for future respiratory outbreaks. G7 countries generally emphasize high-quality diagnostics, regulatory rigor, digital result infrastructure, and integration of PoC testing into healthcare pathways for vulnerable populations and clinical triage. NATO member states consider rapid diagnostics as part of broader resilience, military health readiness, and continuity of operations planning, particularly for deployments, training environments, and critical infrastructure protection.

Key Country Insights Across Major COVID-19 Point-of-Care Testing Markets

The United States has extensive experience with at-home and professional COVID-19 PoC testing, supported by emergency use pathways, pharmacy access, telehealth-enabled reporting, and sustained clinical use in high-risk settings. Canada emphasizes public health governance, provincial healthcare delivery, and quality-assured diagnostics for healthcare facilities, remote communities, and outbreak management. Mexico uses PoC kits to expand access beyond centralized laboratories, particularly in primary care, border regions, and densely populated urban areas. Brazil's large geography and mixed public-private healthcare system make decentralized testing important for respiratory disease surveillance, hospital triage, and access in underserved areas.

The United Kingdom has transitioned from mass population testing toward targeted clinical and public health use, with an emphasis on evidence-based deployment, vulnerable groups, and respiratory infection management. Germany's diagnostics ecosystem is shaped by strong laboratory medicine capabilities, regulatory discipline, and use of PoC testing where rapid decisions are operationally valuable. France continues to apply rapid testing through pharmacies, clinics, and healthcare facilities while aligning use with public health guidance and respiratory disease surveillance. Russia's diagnostic priorities include domestic production capacity, regional access, and integration of rapid testing into healthcare and outbreak monitoring. Italy and Spain, both heavily affected during earlier pandemic waves, continue to rely on PoC testing for clinical triage, healthcare facility screening, and seasonal respiratory virus differentiation.

China remains highly significant due to large-scale manufacturing capacity, domestic surveillance experience, and continued interest in rapid and multiplex diagnostics. India's large population, varied healthcare access, and expanding diagnostics manufacturing base support broad use of affordable PoC kits in urban and rural settings. Japan prioritizes quality, reliability, aging-population care, and integration of rapid diagnostics into clinical workflows. Australia uses PoC testing to support remote healthcare access, aged care protection, and respiratory disease management across dispersed populations. South Korea's strong diagnostics infrastructure, digital health readiness, and infectious disease response capacity position it as an important market for advanced PoC testing and connected respiratory diagnostics.

Actionable Recommendations for Leaders in COVID-19 Detection PoC Kits

Industry leaders should prioritize clinically validated, regulation-ready COVID-19 detection PoC kits that address current respiratory disease realities rather than pandemic-era volume assumptions. Product portfolios should increasingly include multiplex respiratory testing, high-performing antigen formats, rapid molecular options, and digitally connected workflows that support reliable result capture, quality control, and public health reporting. Usability should remain a core design requirement, particularly for self-testing, pharmacy testing, rural clinics, and non-laboratory healthcare settings.

Leaders should invest in variant monitoring, post-market performance surveillance, and robust clinical evidence across symptomatic and asymptomatic populations, different age groups, and real-world sample collection conditions. Supply chains should be diversified for critical inputs such as membranes, reagents, swabs, cartridges, packaging, and electronics. Partnerships with healthcare providers, public health agencies, pharmacies, telehealth platforms, and community health organizations can improve access and responsible use. To strengthen competitiveness, organizations should embed cybersecurity, interoperability, environmental sustainability, and clear user education into product and service models.

Research Methodology for COVID-19 Detection PoC Kits Analysis

This executive summary is developed using a structured secondary research approach focused on verified, data-backed public sources and industry-relevant evidence. The methodology considers guidance and publications from health authorities, regulatory agencies, standards bodies, peer-reviewed scientific literature, public health surveillance resources, medical device regulatory updates, and diagnostics best-practice documentation. The analysis evaluates technology types, clinical use cases, regulatory considerations, regional health system priorities, adoption settings, and emerging innovation themes without relying on market sizing, market share, or forecast estimates.

The research approach emphasizes triangulation of credible evidence across clinical performance expectations, decentralized testing workflows, respiratory virus surveillance needs, and regulatory evolution. Insights are synthesized to support strategic understanding of COVID-19 detection PoC kits across regions, country environments, economic groups, and healthcare delivery models. The methodology also accounts for the transition from emergency pandemic testing toward sustainable respiratory diagnostics, including multiplex testing, digital reporting, AI-enabled interpretation, and quality-assured decentralized care.

Conclusion: COVID-19 PoC Kits as a Foundation for Resilient Respiratory Diagnostics

COVID-19 detection PoC kits continue to play an important role in rapid diagnosis, clinical triage, outbreak control, and respiratory disease surveillance. The sector has evolved from urgent pandemic response to a more mature diagnostics environment defined by quality, usability, regulatory compliance, digital connectivity, and integration with broader respiratory testing. Antigen tests, rapid molecular assays, and multiplex platforms each serve distinct needs across healthcare settings, community access points, and resource-variable environments.

Future success will depend on reliable clinical performance, adaptability to variant evolution, responsible AI integration, strong supply chain resilience, and alignment with regional health system priorities. Organizations that combine validated testing technology with accessible deployment models, interoperable reporting, and clear clinical value will be best positioned to support ongoing COVID-19 management and preparedness for future respiratory disease threats.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. COVID-19 Detection PoC Kits Market, by Product Type

  • 7.1. Introduction
  • 7.2. Molecular POC Test Kits
  • 7.3. Antigen POC Test Kits
  • 7.4. Antibody POC Test Kits
  • 7.5. Multiplex Respiratory POC Test Kits

8. COVID-19 Detection PoC Kits Market, by Detection Technology

  • 8.1. Introduction
  • 8.2. Lateral Flow Assay Technology
  • 8.3. Reverse Transcription Polymerase Chain Reaction Technology
  • 8.4. Isothermal Nucleic Acid Amplification Technology
  • 8.5. CRISPR Diagnostic Technology
  • 8.6. Fluorescence Immunoassay Technology
  • 8.7. Microfluidics-Based Technology
  • 8.8. Biosensor-Based Technology

9. COVID-19 Detection PoC Kits Market, by Sample Type

  • 9.1. Introduction
  • 9.2. Nasopharyngeal Swab
  • 9.3. Oropharyngeal Swab
  • 9.4. Saliva
  • 9.5. Nasal Swab Samples
  • 9.6. Blood Samples
  • 9.7. Sputum Samples

10. COVID-19 Detection PoC Kits Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacy
  • 10.3. Online Pharmacy
  • 10.4. Retail Pharmacy

11. COVID-19 Detection PoC Kits Market, by Application

  • 11.1. Introduction
  • 11.2. Clinical Testing
  • 11.3. Research
  • 11.4. Self Testing
  • 11.5. Surveillance

12. COVID-19 Detection PoC Kits Market, by End User

  • 12.1. Introduction
  • 12.2. Diagnostic Centers
  • 12.3. Home Care
  • 12.4. Hospitals

13. COVID-19 Detection PoC Kits Market, by Mode Of Use

  • 13.1. Introduction
  • 13.2. Professional-Use POC Kits
  • 13.3. Self-Test POC Kits

14. COVID-19 Detection PoC Kits Market, by Test Result Time

  • 14.1. Introduction
  • 14.2. Less Than 15 Minutes
  • 14.3. 15 To 30 Minutes
  • 14.4. More Than 30 Minutes

15. COVID-19 Detection PoC Kits Market, by Region

  • 15.1. Asia-Pacific
  • 15.2. North America
  • 15.3. Latin America
  • 15.4. Europe
  • 15.5. Middle East
  • 15.6. Africa

16. COVID-19 Detection PoC Kits Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. COVID-19 Detection PoC Kits Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2025
  • 18.2. FPNV Positioning Matrix, 2025
  • 18.3. Market Concentration Analysis, 2025
    • 18.3.1. Concentration Ratio (CR)
    • 18.3.2. Herfindahl Hirschman Index (HHI)
  • 18.4. Recent Developments & Impact Analysis, 2025
  • 18.5. Product Portfolio Analysis, 2025
  • 18.6. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. Abbott Laboratories
  • 19.2. Access Bio, Inc.
  • 19.3. ACON Laboratories, Inc.
  • 19.4. ANP Technologies, Inc.
  • 19.5. Azure Biotech, Inc.
  • 19.6. Becton, Dickinson And Company
  • 19.7. bioMerieux SA
  • 19.8. CorDx Inc.
  • 19.9. Danaher Corporation
  • 19.10. DiaSorin S.p.A.
  • 19.11. F. Hoffmann-La Roche Ltd
  • 19.12. Genabio Diagnostics Inc.
  • 19.13. GenBody Inc.
  • 19.14. Guangzhou Wondfo Biotech Co., Ltd.
  • 19.15. iHealth Labs, Inc.
  • 19.16. InBios International, Inc.
  • 19.17. Lex Diagnostics Limited
  • 19.18. Maxim Biomedical, Inc.
  • 19.19. MicroGEM U.S., Inc.
  • 19.20. Nano-Ditech Corporation
  • 19.21. Nuclein, LLC
  • 19.22. OSANG Healthcare Co., Ltd.
  • 19.23. Pfizer Inc.
  • 19.24. Princeton BioMeditech Corporation
  • 19.25. QIAGEN N.V.
  • 19.26. Qorvo, Inc.
  • 19.27. QuidelOrtho Corporation
  • 19.28. SD Biosensor, Inc.
  • 19.29. SEKISUI Chemical Co., Ltd.
  • 19.30. Shenzhen Watmind Medical Co., Ltd.
  • 19.31. Siemens Healthineers AG
  • 19.32. Thermo Fisher Scientific Inc.
  • 19.33. Visby Medical, Inc.
  • 19.34. Xiamen Boson Biotech Co., Ltd.
  • 19.35. Zhejiang Orient Gene Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COVID-19 DETECTION POC KITS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL COVID-19 DETECTION POC KITS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL COVID-19 DETECTION POC KITS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL COVID-19 DETECTION POC KITS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL COVID-19 DETECTION POC KITS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 29. GLOBAL COVID-19 DETECTION POC KITS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL COVID-19 DETECTION POC KITS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MOLECULAR POC TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MOLECULAR POC TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MOLECULAR POC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTIGEN POC TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANTIGEN POC TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTIGEN POC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANTIBODY POC TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTIBODY POC TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANTIBODY POC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MULTIPLEX RESPIRATORY POC TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MULTIPLEX RESPIRATORY POC TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MULTIPLEX RESPIRATORY POC TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LATERAL FLOW ASSAY TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LATERAL FLOW ASSAY TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LATERAL FLOW ASSAY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CRISPR DIAGNOSTIC TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CRISPR DIAGNOSTIC TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CRISPR DIAGNOSTIC TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLUORESCENCE IMMUNOASSAY TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FLUORESCENCE IMMUNOASSAY TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLUORESCENCE IMMUNOASSAY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MICROFLUIDICS-BASED TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MICROFLUIDICS-BASED TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MICROFLUIDICS-BASED TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOSENSOR-BASED TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOSENSOR-BASED TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOSENSOR-BASED TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NASOPHARYNGEAL SWAB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NASOPHARYNGEAL SWAB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NASOPHARYNGEAL SWAB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL OROPHARYNGEAL SWAB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OROPHARYNGEAL SWAB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OROPHARYNGEAL SWAB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NASAL SWAB SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NASAL SWAB SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NASAL SWAB SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SPUTUM SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SPUTUM SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SPUTUM SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ONLINE PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ONLINE PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ONLINE PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RETAIL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RETAIL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RETAIL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CLINICAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CLINICAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CLINICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SELF TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SELF TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SELF TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURVEILLANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURVEILLANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PROFESSIONAL-USE POC KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PROFESSIONAL-USE POC KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PROFESSIONAL-USE POC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SELF-TEST POC KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SELF-TEST POC KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SELF-TEST POC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL LESS THAN 15 MINUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL LESS THAN 15 MINUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL LESS THAN 15 MINUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL 15 TO 30 MINUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL 15 TO 30 MINUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL 15 TO 30 MINUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MORE THAN 30 MINUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MORE THAN 30 MINUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MORE THAN 30 MINUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 172. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 199. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 208. NATO COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. NATO COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. NATO COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. NATO COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 227. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 236. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 244. MEXICO COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 245. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED KINGDOM COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 263. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 271. GERMANY COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 272. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 277. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 280. FRANCE COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 281. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 284. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 289. RUSSIA COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 290. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 293. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 295. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 298. ITALY COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 299. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 302. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 304. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 305. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 307. SPAIN COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 308. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 309. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 313. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 317. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 320. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 324. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 325. INDIA COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 326. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 327. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 329. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 331. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 332. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY MODE OF USE, 2018-2032 (USD MILLION)
  • TABLE 334. JAPAN COVID-19 DETECTION POC KITS MARKET SIZE, BY TEST RESULT TIME, 2018-2032 (USD MILLION)
  • TABLE 335. AUSTRALIA COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. AUSTRALIA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. AUSTRALIA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 338. AUSTRALIA COVID-19 DETECTION POC